Search Results - "Kueider‐Paisley, Alexandra"
-
1
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
Published in Nature communications (02-03-2020)“…Late-onset Alzheimer’s disease (AD) can, in part, be considered a metabolic disease. Besides age, female sex and APOE ε4 genotype represent strong risk factors…”
Get full text
Journal Article -
2
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Published in Alzheimer's & dementia (01-02-2019)“…Bile acids (BAs) are the end products of cholesterol metabolism produced by human and gut microbiome co-metabolism. Recent evidence suggests gut microbiota…”
Get full text
Journal Article -
3
Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent Manner
Published in Advanced science (01-03-2024)“…Sex disparities in serum bile acid (BA) levels and Alzheimer's disease (AD) prevalence have been established. However, the precise link between changes in…”
Get full text
Journal Article -
4
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
Published in Alzheimer's & dementia (01-01-2019)“…Increasing evidence suggests a role for the gut microbiome in central nervous system disorders and a specific role for the gut-brain axis in neurodegeneration…”
Get full text
Journal Article -
5
Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
Published in Neuron (Cambridge, Mass.) (03-06-2020)“…Evidence suggests interplay among the three major risk factors for Alzheimer’s disease (AD): age, APOE genotype, and sex. Here, we present comprehensive…”
Get full text
Journal Article -
6
Comparison of Approaches for Equating Different Versions of the Mini-Mental State Examination Administered in 22 Studies
Published in American journal of epidemiology (31-12-2019)“…Abstract The Mini-Mental State Examination (MMSE) is one of the most widely used cognitive screening tests in the world. However, its administration and…”
Get full text
Journal Article -
7
Predictive metabolic networks reveal sex‐ and APOE genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease
Published in Alzheimer's & dementia (01-02-2023)“…Introduction Late‐onset Alzheimer's disease (LOAD) is a complex neurodegenerative disease characterized by multiple progressive stages, glucose metabolic…”
Get full text
Journal Article -
8
Peripheral serum metabolomic profiles inform central cognitive impairment
Published in Scientific reports (20-08-2020)“…The incidence of Alzheimer's disease (AD) increases with age and is becoming a significant cause of worldwide morbidity and mortality. However, the metabolic…”
Get full text
Journal Article -
9
Investigating the importance of acylcarnitines in Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2021)“…Background L‐carnitine is present in the mammalian cells as free carnitine (FC) and acylcarnitine and the adult human brain contains almost 10% of long chain…”
Get full text
Journal Article -
10
Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau
Published in Alzheimer's & dementia (01-09-2020)“…Introduction Altered lipid metabolism is implicated in Alzheimer's disease (AD), but the mechanisms remain obscure. Aging‐related declines in circulating…”
Get full text
Journal Article -
11
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease
Published in Communications biology (08-10-2022)“…Dysregulation of sphingomyelin and ceramide metabolism have been implicated in Alzheimer’s disease. Genome-wide and transcriptome-wide association studies have…”
Get full text
Journal Article -
12
ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease
Published in Alzheimer's research & therapy (26-12-2022)“…Alzheimer's disease (AD) shares risk factors with cardiovascular disease (CVD) and dysregulated cholesterol metabolism is a mechanism common to both diseases…”
Get full text
Journal Article -
13
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
Published in JAMA network open (03-07-2019)“…Increasing evidence suggests an important role of liver function in the pathophysiology of Alzheimer disease (AD). The liver is a major metabolic hub;…”
Get full text
Journal Article -
14
Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease
Published in Cell reports. Medicine (17-11-2020)“…Increasing evidence suggests Alzheimer's disease (AD) pathophysiology is influenced by primary and secondary bile acids, the end product of cholesterol…”
Get full text
Journal Article -
15
Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer’s disease
Published in Scientific reports (29-07-2024)“…Inflammation is an important factor in Alzheimer’s disease (AD). An NMR measurement in plasma, glycoprotein acetyls (GlycA), captures the overall level of…”
Get full text
Journal Article -
16
A blood-based signature of cerebrospinal fluid Aβ 1-42 status
Published in Scientific reports (01-12-2019)“…It is increasingly recognized that Alzheimer's disease (AD) exists before dementia is present and that shifts in amyloid beta occur long before clinical…”
Get full text
Journal Article -
17
Serum metabolome informs neuroimaging biomarkers for Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2020)“…Background Accumulating evidence suggests that Alzheimer’s disease (AD) patients display metabolic dysfunction. Metabolomics is a powerful tool for studying…”
Get full text
Journal Article -
18
Serum metabolome informs neuroimaging biomarkers for Alzheimer’s disease: Genome‐metabolome‐phenome: Towards an integrated molecular atlas for Alzheimer's disease
Published in Alzheimer's & dementia (01-12-2020)“…Abstract Background Accumulating evidence suggests that Alzheimer’s disease (AD) patients display metabolic dysfunction. Metabolomics is a powerful tool for…”
Get full text
Journal Article -
19
Transcriptomics, metabolomics, lipidomics, metabolic flux and mGWAS analyses of sphingolipid pathway highlights novel drugs for Alzheimer’s disease
Published in Alzheimer's & dementia (01-12-2021)“…Background Alzheimer’s disease (AD) related neurodegeneration has been correlated with metabolic dysfunction. Sphingomyelins (SM), a class of lipids found in…”
Get full text
Journal Article -
20